Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elvira Pota

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Frontiers in Pediatrics|August 8, 2022
The safety of blinatumomab in pediatric patients with acute lymphoblastic leukemia: A systematic review and meta-analysisMaria Maddalena Marrapodi, Annamaria Mascolo, Gabriella di Mauro, et al.
Pharmacological Research|September 30, 2018
Bortezomib and endocannabinoid/endovanilloid system: a synergism in osteosarcomaFrancesca Punzo, Chiara Tortora, Daniela Di Pinto, et al.
La Pediatria Medica E Chirurgica : Medical and Surgical Pediatrics|December 24, 2016
Osteonecrosis as a complication in pediatric patients with acute lymphoblastic leukemiaIlaria Riccio, Elvira Pota, Marco Marcarelli, et al.
Oncotarget|August 1, 2020
Can Denosumab be used in combination with Doxorubicin in Osteosarcoma?Francesca Punzo, Chiara Tortora, Maura Argenziano, et al.
Oncotarget|July 15, 2021
Eltrombopag and its iron chelating properties in pediatric acute myeloid leukemiaMaura Argenziano, Chiara Tortora, Alessandra Di Paola, et al.
Plos One|July 21, 2022
Alteration of osteoclast activity in childhood cancer survivors: Role of iron and of CB2/TRPV1 receptorsFrancesca Rossi, Chiara Tortora, Martina Di Martino, et al.
Frontiers in Pharmacology|May 28, 2020
Safety of Anticancer Agents Used in Children: A Focus on Their Off-Label Use Through Data From the Spontaneous Reporting SystemAnnamaria Mascolo, Cristina Scavone, Michele Bertini, et al.
Pharmaceuticals (Basel, Switzerland)|September 28, 2021
Osteosarcoma in Children: Not Only ChemotherapyMaura Argenziano, Chiara Tortora, Elvira Pota, et al.
Current Cancer Drug Targets|December 31, 2020
Effects of Iron Chelation in OsteosarcomaMaura Argenziano, Alessandra Di Paola, Chiara Tortora, et al.
International Journal of Molecular Sciences|October 26, 2024
Curcumin and Methotrexate: A Promising Combination for Osteosarcoma Treatment via Hedgehog Pathway InhibitionGiulia Giliberti, Maria Maddalena Marrapodi, Giuseppe Di Feo, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Frontiers in Pediatrics|August 8, 2022
The safety of blinatumomab in pediatric patients with acute lymphoblastic leukemia: A systematic review and meta-analysisMaria Maddalena Marrapodi, Annamaria Mascolo, Gabriella di Mauro, et al.
Pharmacological Research|September 30, 2018
Bortezomib and endocannabinoid/endovanilloid system: a synergism in osteosarcomaFrancesca Punzo, Chiara Tortora, Daniela Di Pinto, et al.
La Pediatria Medica E Chirurgica : Medical and Surgical Pediatrics|December 24, 2016
Osteonecrosis as a complication in pediatric patients with acute lymphoblastic leukemiaIlaria Riccio, Elvira Pota, Marco Marcarelli, et al.
Oncotarget|August 1, 2020
Can Denosumab be used in combination with Doxorubicin in Osteosarcoma?Francesca Punzo, Chiara Tortora, Maura Argenziano, et al.
Oncotarget|July 15, 2021
Eltrombopag and its iron chelating properties in pediatric acute myeloid leukemiaMaura Argenziano, Chiara Tortora, Alessandra Di Paola, et al.
Plos One|July 21, 2022
Alteration of osteoclast activity in childhood cancer survivors: Role of iron and of CB2/TRPV1 receptorsFrancesca Rossi, Chiara Tortora, Martina Di Martino, et al.
Frontiers in Pharmacology|May 28, 2020
Safety of Anticancer Agents Used in Children: A Focus on Their Off-Label Use Through Data From the Spontaneous Reporting SystemAnnamaria Mascolo, Cristina Scavone, Michele Bertini, et al.
Pharmaceuticals (Basel, Switzerland)|September 28, 2021
Osteosarcoma in Children: Not Only ChemotherapyMaura Argenziano, Chiara Tortora, Elvira Pota, et al.
Current Cancer Drug Targets|December 31, 2020
Effects of Iron Chelation in OsteosarcomaMaura Argenziano, Alessandra Di Paola, Chiara Tortora, et al.
International Journal of Molecular Sciences|October 26, 2024
Curcumin and Methotrexate: A Promising Combination for Osteosarcoma Treatment via Hedgehog Pathway InhibitionGiulia Giliberti, Maria Maddalena Marrapodi, Giuseppe Di Feo, et al.
Pageof 3